| Literature DB >> 31617176 |
Laura Menotti1, Valerio Leoni2, Valentina Gatta2, Biljana Petrovic3, Andrea Vannini2, Simona Pepe2, Tatiana Gianni2, Gabriella Campadelli-Fiume4.
Abstract
Since the cloning of the herpes simplex virus (HSV) genome as BAC (bacterial artificial chromosome), the genetic engineering of the viral genome has become readily feasible. The advantage is that the modification of the animal virus genome is carried out in bacteria, with no replication or production of viral progeny, and is separated from the reconstitution or regeneration of the recombinant virus in mammalian cells. This allows an easy engineering of essential genes, as well. Many technologies have been developed for herpesvirus BAC engineering. In our hands the most powerful is galK recombineering that exploits a single marker (galK) for positive and negative selection and PCR amplicons for seamless modification in the desired genome locus. Here we describe the engineering of the HSV recombinant BAC 115 by the insertion of a heterologous cassette for the expression of murine interleukin 12 (mIL12) in the intergenic sequence between US1 and US2 ORFs.Entities:
Keywords: Herpes simplex virus; Interleukin 12; Oncolytic virotherapy; Transgene expression; Virus arming; Virus engineering; galK recombineering
Year: 2020 PMID: 31617176 DOI: 10.1007/978-1-4939-9814-2_7
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745